Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

KALA

KALA BIO (KALA)

KALA BIO Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KALA
DateTimeSourceHeadlineSymbolCompany
01/07/20257:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
01/07/20257:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
01/07/20257:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
01/03/20256:07AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KALAKALA BIO Inc
12/31/20243:13PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:KALAKALA BIO Inc
12/30/20248:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
12/30/20247:00AMGlobeNewswire Inc.KALA BIO Announces $10,750,000 Private PlacementNASDAQ:KALAKALA BIO Inc
11/27/20247:00AMGlobeNewswire Inc.KALA BIO to Present at Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
11/14/20243:49PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KALAKALA BIO Inc
11/12/20243:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KALAKALA BIO Inc
11/12/20247:00AMGlobeNewswire Inc.KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
09/25/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
09/06/20243:06PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:KALAKALA BIO Inc
08/08/20247:00AMGlobeNewswire Inc.KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceNASDAQ:KALAKALA BIO Inc
08/06/20247:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
08/06/20247:00AMGlobeNewswire Inc.KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
07/31/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KALAKALA BIO Inc
07/31/20243:08PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KALAKALA BIO Inc
07/25/20243:10PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:KALAKALA BIO Inc
07/17/20244:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KALAKALA BIO Inc
07/16/20244:34PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KALAKALA BIO Inc
07/08/20247:54PMEdgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:KALAKALA BIO Inc
06/27/20247:00AMGlobeNewswire Inc.KALA BIO Announces $12,500,000 Private PlacementNASDAQ:KALAKALA BIO Inc
06/12/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
06/12/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
06/12/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
06/12/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
06/03/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
06/03/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
06/03/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
 Showing the most relevant articles for your search:NASDAQ:KALA